Randomized Multicenter Phase II Trial Evaluating the Sequencing of PD-1 Inhibition with Pembrolizumab (P) and Standard Platinum-Based Chemotherapy (C) in Patients (pts) with Metastatic Non-Small Cell Lung Cancer (NSCLC) (AFT-09).
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined